Qube Research & Technologies (QRT)
XENT

Qube Research & Technologies (QRT)’s Intersect ENT, Inc XENT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-231,251
Closed -$6.48M – 3347
2022
Q1 		$6.48M Buy
231,251
+110,863
+92% +$3.04M 0.05% 445
2021
Q4 		$3.29M Buy
120,388
+68,856
+134% +$1.87M 0.03% 682
2021
Q3 		$1.4M Buy
+51,532
New +$1.27M 0.02% 786

Qube Research & Technologies (QRT)'s XENT Position: Q2 2022 in Review

Qube Research & Technologies (QRT) sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 231,251 shares — an estimated $6.48M sold.

Qube Research & Technologies (QRT) first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $6.48M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Qube Research & Technologies (QRT) reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 231,251 Intersect ENT, Inc shares in Q2 2022, an estimated $6.48M.
  • Qube Research & Technologies (QRT) first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Intersect ENT, Inc position peaked at $6.48M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.